brimonidine tartrate 2 MG/ML Ophthalmic Solution
brimonidine tartrate
RxCUI: 861200
What the CMS Formulary Data Shows for brimonidine tartrate 2 MG/ML Ophthalmic Solution
Per the CMS 2026 Part D formulary file, brimonidine tartrate 2 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 861200, generic name brimonidine tartrate) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.5.
Real-world access to brimonidine tartrate 2 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 573,214 Part D beneficiaries filled brimonidine tartrate 2 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $88,900,177 and an average per-beneficiary annual cost of $155.09. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry brimonidine tartrate 2 MG/ML Ophthalmic Solution today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 573,214
- Total spending
- $88,900,177
- Avg per beneficiary
- $155.09
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering brimonidine tartrate 2 MG/ML Ophthalmic Solution
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is brimonidine tartrate 2 MG/ML Ophthalmic Solution covered by Medicare Part D?
Yes, brimonidine tartrate 2 MG/ML Ophthalmic Solution is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is brimonidine tartrate 2 MG/ML Ophthalmic Solution on Medicare Part D plans?
brimonidine tartrate 2 MG/ML Ophthalmic Solution averages Tier 1.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does brimonidine tartrate 2 MG/ML Ophthalmic Solution require prior authorization?
0% of Part D formularies require prior authorization for brimonidine tartrate 2 MG/ML Ophthalmic Solution. Step therapy: 0%. Quantity limits: 0.6%.
How much does Medicare spend on brimonidine tartrate 2 MG/ML Ophthalmic Solution?
In 2023, total Medicare Part D spending on brimonidine tartrate 2 MG/ML Ophthalmic Solution was $88,900,177, covering 573,214 beneficiaries. The average spend per beneficiary was $155.09.
Read our methodology - how this data is sourced, computed, and verified.